CRISPR-GPT for Agentic Automation of Gene-editing Experiments
This work addresses the problem of making complex gene-editing experiments more accessible to beginner biological researchers, representing an incremental application of existing LLM technology to a specific domain.
The researchers tackled the challenge of automating CRISPR-based gene-editing experiment design, which requires deep expertise, by developing CRISPR-GPT, an LLM agent augmented with domain knowledge and tools to assist with tasks like selecting CRISPR systems and designing guide RNAs. They validated its effectiveness in a real-world use case, demonstrating its potential to help non-expert researchers.
The introduction of genome engineering technology has transformed biomedical research, making it possible to make precise changes to genetic information. However, creating an efficient gene-editing system requires a deep understanding of CRISPR technology, and the complex experimental systems under investigation. While Large Language Models (LLMs) have shown promise in various tasks, they often lack specific knowledge and struggle to accurately solve biological design problems. In this work, we introduce CRISPR-GPT, an LLM agent augmented with domain knowledge and external tools to automate and enhance the design process of CRISPR-based gene-editing experiments. CRISPR-GPT leverages the reasoning ability of LLMs to facilitate the process of selecting CRISPR systems, designing guide RNAs, recommending cellular delivery methods, drafting protocols, and designing validation experiments to confirm editing outcomes. We showcase the potential of CRISPR-GPT for assisting non-expert researchers with gene-editing experiments from scratch and validate the agent's effectiveness in a real-world use case. Furthermore, we explore the ethical and regulatory considerations associated with automated gene-editing design, highlighting the need for responsible and transparent use of these tools. Our work aims to bridge the gap between beginner biological researchers and CRISPR genome engineering techniques, and demonstrate the potential of LLM agents in facilitating complex biological discovery tasks. The published version of this draft is available at https://www.nature.com/articles/s41551-025-01463-z.